Besides the traditional use of insects such as termites and grasshoppers as part of the Nigerian diet for their nutritive values, scientists have bioengineered these local delicacies in the treatment of cancer, diabetes, rheumatoid arthritis, Human Immuno-deficiency Virus (HIV), wounds among other benefits. CHUKWUMA MUANYA writes.
A study published in the Journal of Agriculture and Food Chemistry found that insects could provide as much magnesium, iron, and other nutrients as steak.
And researchers at the American Chemical Society (ACS) found grasshoppers and crickets to be a far better source of many nutrients, particularly iron, compared to beef.
Grasshoppers, mealworms, termites and crickets all had higher concentrations of chemically available calcium, copper and zinc than the sirloin.
In Nigeria, termites are usually roasted and eaten as food, mostly during the rainy season.
Indian researchers from Department of Biological Sciences, Presidency University, Kolkata; Department of Zoology, Darjeeling Government College, West Bengal; and Department of Zoology, Scottish Church College, Kolkata explored developments in bioengineering natural products from insects with potential use in modern medicines as well as in utilisation of insects as models for studying essential mammalian processes such as immune responses to pathogens.
The study was published in World Science News.
The researchers listed natural products derived from insects possess medicinal value:
Honey bee products used as medicine Bee products such as honey, venom have been used in folk medicine for thousands of years for treating wounds, ulcers, inflammation, infections, pain, allergies and cancer.
Bee venom therapy, the therapeutic application of bee venom have been used in traditional medicine to treat diseases, such as arthritis, rheumatism, pain, cancerous tumors and kin diseases. Bee venom contains a variety of peptides including melittin, apamin, adolapin, the mast cell-degranulating peptide, enzymes (phospolipase A2), biologically active amines (that is histamine and epinephrine) and nonpeptide components with a variety of pharmaceutical properties.
Cancer treatment Bee venom has been widely used in the treatment of tumours. Several cancer cells, including renal, lung, liver, prostate, mammary gland as well as leukemia cells can be targets of bee venom peptides such as melittin and phospholipase A2.
In recent study scientists reported that bee venom can induce apoptosis in cancer cells (in human leukemic U937cells) the key regulators in bee venom induced apoptosis are Bcl-2 and caspase-3 through down regulation of the ERK and Akt signal pathway. Melittin, a water-soluble toxic peptide derived from bee venom of Apis mellifera was reported to have inhibitory effects on hepatocellular carcinoma. Melittin inhibits tumor cell metastasis by reducing motility and migration via the suppression of Rac-1 dependent pathway, suggesting that melittin is a potent therapeutic agent for hepatocellular carcinoma. Melittin prevents liver cancer cells metastasis through inhibition of the Rac-1-dependent pathway.
Treatment for rheumatoid arthritis Bee venom induces apoptosis in rheumatoid synovial cells through a decrease in BCL2 expression and an increase in BAX and caspase-3 expression. Bee venom induces apoptosis through caspase-3 activation in synovial fibroblasts of patients with rheumatoid arthritis.
Controlling diabetes Hyperglycemia in diabetes leads to increased protein glycation resulting in structural and functional alteration in proteins. Recent studies showed that bee venom prevents glycation induced increasing in beta-sheet structure decreasing in free amino groups, altering in the secondary structure and heme degradation in the hemoglobin. Hence, bee venom has the potential to be used as a natural drug to prevent diabetes complications. Honeybee venom decreases the complications of diabetes by preventing haemoglobin glycation.
Antioxidant Free radicals are ubiquitous in our body and are generated by physiological processes, including aerobic metabolism and inflammatory responses, to eliminate invading pathogenic microorganisms. Target of free radicals in inflammation include Deoxyribonucleic Acid (DNA)/genetic material, proteins, Ribonucleic Acid (RNA) and lipids. An antioxidant is a molecule capable of slowing or preventing the oxidation of other molecules and so to prevent such changes. Oxidative stress is thought to contribute to the development of chronic and degenerative diseases such as cancer, autoimmune disorders, aging, rheumatoid arthritis, cardiovascular and neurodegenerative diseases. Propolis, pollen, honey have the highest antioxidant activities. Bee venom is a potent antioxidant and possesses radio-protecting actions.
Treatment for HIV Nanoparticles carrying a toxin found in bee venom can destroy Human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, researchers at Washington University School of Medicine in St. Louis have shown. The finding is an important step toward developing a vaginal gel that may prevent the spread of HIV, the virus that causes AIDS. Bee venom contains a potent toxin called melittin that can poke holes in the protective envelope that surrounds HIV virus as well as other viruses. This melittin is loaded with nanoparticles, which do not harm surrounding normal cells. The nanoparticles attack an essential part of the virus structure.
Since melittin attacks double-layered membranes indiscriminately this concept is not limited to HIV. Many viruses, including hepatitis B and C rely on the same kind of protective envelope and would be vulnerable to melittin-loaded nanoparticles. Scientists also said that these nanoparticles are easy to manufacture in large enough quantities to supply them for future clinical trials.
Maggot products Maggot therapy is now commonly used for many types of infected wounds such as diabetic foot wounds, postoperative infections, bedsores, and leg ulcers, in the United States (US), Israel, and Europe. The larvae of the blowfly, Lucilia sericata, are frequently used although other species have also been tried such as Lucilia cuprina, Phormia regina, and Calliphora vicina. The use of L. sericata larvae for treating wounds has been recognised by the U.S. Food and Drug Administration and the United Kingdom (UK) Prescription Pricing Authority. Sterile maggots can therefore be officially prescribed.
Ant venom as medicine Ants have been used as medicine, owing to their special active substances such as citral, ATP, histamine, growth hormone, superoxide dismutase etc. Pachycondyla sennaarensis, the samsum ant venom possesses many pharmacological effects as reducing inflammation, relieving pain, inhibition of tumor growth, hepatitis treatment, liver protection. According to Bai et al., solenopsin A, a primary alkaloid obtained from fire ant Solenopsis invicta exhibits antiangiogenic activity; this toxin has the ability to inhibit a series of kinases involving in angiogenesis mechanism.
Polyrachisla mellidens, a medicinal ant used in Chinese medicine, was confirmed to exert potent analgesic and anti-inflammatory actions. Its therapeutic efficacy in the treatment of various inflammatory disorders had been reported.
Beetle products Many of the Blister beetles (Coleoptera: Meloidae) produce toxic defensive secretions, which upon contact with the skin cause blistering. One such toxin is cantharidin, which has been extracted from Mylabris caragnae, the dried bodies of which have been used in Chinese Folk Medicine since the 13th century for the removal of warts and forever 2000 years for the treatment of cancer.
Canthardin is a monoterpene derived from the bodies of several types of blister beetle, including Mylabris phalerata and M. cichorii (Chinese blister beetles) and this compound is stored in the beetle hemolymph and making up about five per cent of body dry weight. Cantharadin has been found to inhibit the growth of human leukemic cells in vitro. In contrast to other chemotherapeutic agents, cantharadin acts as leukemia progenitor and stem cells.
Several derivatives of cantharadin also retard the growth of prostate, oral, colon, cervical, gall bladder cancer cell lines.
Recently in the year 2007 Huang et al. showed that growth inhibition and killing of human colorectal cancer cells by cantharidin was both time- and dose-dependent. The cantharidin exposure reduced CDK1 kinase activity, which led to failure of the cells to progress from G2 to M phases in the cell cycle. In addition, the colorectal cells were killed by apoptosis, which was induced through the mitochondrial and death receptor pathways and activation of caspases.
Shou et al have studied other effects of cantharidin in human breast cancer cells. They reported that cantharidin resulted in apoptosis and reduced growth, adhesion and migration of the cancer cells.
Wasp venom in cancer therapy Scientists from the Institute for Biomedical Research (IRB) Barcelona have carried out successful in vitro tests using wasp venom to kill cancer cells. The peptide from wasp venom has the ability to form pores in the cell plasma membrane, penetrate into the cell and finally, cause its death either by necrosis or by triggering apoptosis. However, this powerful natural weapon can not only damage tumor cells but also affect healthy cells. As such the researchers designed a means of transporting the peptide to the tumour and making it accumulate in a specific and controlled manner. The system consists of a decorated carrier polymer with two components: a peptide that is bound to a tumor cell receptor and the cytotoxic peptide of the wasp venom.
In vitro experiments show that the substance is adequately distributed within the tumor cells and causes their death, while healthy cells, such as red blood cells, are not affected.
Wasp venom contains Polybia MPI (from venom of the social wasp Polybia paulista), which shows anti tumour activity. Polybia MPI is able to target non-polar lipid cell membrane, forming ion permeable channels, leading to depolarization irreversible cytolysis and finally cell death. It has been shown that Polybia MPI can significantly inhibit the proliferation of tumor cells and associated endothelial cells by membrane disrupting.
Fujiwara et al. isolated and determined the structure of anti cancer molecule from the outer envelop of the social wasp Vespa simillima. A biologically active quinone, 7,8-seco-para-ferruginone exhibited a growth inhibitory effect on rat liver cancer cells. The authors suggest that the cytotoxic activity is related to the morphological changes that induce apoptosis of the cells exposed to this molecule.
Moore et al. showed that cecropins are active against several mammalian lymphomas and leukemias in vitro and a preliminary in vivo study showed that cecropin B increases the survival time of mice bearing murine ascitic colon adenocarcinoma cells.
Suttmann et al. showed that cecropin A and B inhibit the viability proliferation of bladder cancer cells, but with no effect on fibroblasts. The selective antitumor action mechanism of these peptides depends on disruption of target cell membrane resulting in irreversible cytolysis and cell destruction. Both peptides may offer novel strategies for the treatment of bladder cancer cells with limited cytotoxic effects on benign cells.
8 hours ago Features
8 hours ago Health
8 hours ago Science
Read this article:
Insects employed to treat cancer, HIV - Guardian
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021